<div dir="ltr">Hi Dan,<div><br></div><div>I can't find the toplevel version.</div><div><br></div><div>Andreu.</div></div><div class="gmail_extra"><br clear="all"><div><div class="gmail_signature" data-smartmail="gmail_signature"><div dir="ltr"><div><div dir="ltr"><div><div dir="ltr"><div><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><font size="2"><b>Andreu Paytuví</b></font></div><div dir="ltr"><font size="1">Bioinformatician & PhD candidate</font></div><div dir="ltr"><div><img src="http://www.pcb.ub.edu/portal/delegate/ImageGetter?empresaId=ENT_006551" height="72" width="200"><br></div><div><span style="font-size:12.8000001907349px"><b><font color="#0b5394">Sequentia Biotech SL</font></b></span><br></div><div><font size="1"><a href="http://www.sequentiabiotech.com" target="_blank">www.sequentiabiotech.com</a></font></div><div><font size="1"><a href="http://www.linkedin.com/company/sequentia-biotech" target="_blank">Find <b>Sequentia</b> at LinkedIn</a></font></div><div><div><font color="#0b5394" size="1">Parc Cientific de Barcelona</font></div><div><span style="color:rgb(11,83,148);font-size:x-small">C/Baldiri Reixac, 4-8</span><font color="#0b5394" size="1"><br>Torre R, 02 A6-A7<br>08028 Barcelona<br><br></font><font size="1"><span><i><span style="font-family:Arial,sans-serif;background-image:initial;background-repeat:initial" lang="EN-US">This
message is intended exclusively for its addressee and may contain
information considered CONFIDENTIAL and protected by professional
privilege. If you are not the intended recipient you are hereby notified
that any dissemination, copy or disclosure of this communication is
strictly prohibited by law. If this message has been mistakenly
received, please immediately notify us via e-mail and delete it.<br><br></span></i></span></font><p style="text-align:left;margin:0cm 0cm 0.0001pt"><font size="1"><i><span style="font-family:Arial,sans-serif;background-image:initial;background-repeat:initial">Este mensaje está
dirigido exclusivamente a su destinatario y puede contener información
privilegiada o CONFIDENCIAL. Si no es Vd. el destinatario indicado,
queda notificado de que la utilización, divulgación y/o copia sin
autorización está prohibida en virtud de la legislación vigente. Si ha
recibido este mensaje por error, le rogamos que nos lo comunique
inmediatamente por esta misma vía y proceda a su eliminación.</span></i></font></p><p style="margin:0cm 0cm 0.0001pt;text-align:justify"><font size="1"><i><span style="font-family:Arial,sans-serif;background-image:initial;background-repeat:initial"><br></span></i></font></p></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
<br><div class="gmail_quote">On 29 November 2016 at 21:38, Dan Staines <span dir="ltr"><<a href="mailto:dstaines@ebi.ac.uk" target="_blank">dstaines@ebi.ac.uk</a>></span> wrote:<br><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">Apologies, the files are now present - please let us know if you have any more problems.<span class="HOEnZb"><font color="#888888"><br>
<br>
Dan.<br>
<br>
-- <br>
Dan Staines, PhD<br>
Genomics Technology Infrastructure Coordinator<br>
EMBL-EBI, Wellcome Trust Genome Campus<br>
Cambridge CB10 1SD, UK<br>
Tel: <a href="tel:%2B44-%280%291223-492507" value="+441223492507" target="_blank">+44-(0)1223-492507</a><br>
<br>
______________________________<wbr>_________________<br>
Dev mailing list <a href="mailto:Dev@ensembl.org" target="_blank">Dev@ensembl.org</a><br>
Posting guidelines and subscribe/unsubscribe info: <a href="http://lists.ensembl.org/mailman/listinfo/dev" rel="noreferrer" target="_blank">http://lists.ensembl.org/mailm<wbr>an/listinfo/dev</a><br>
Ensembl Blog: <a href="http://www.ensembl.info/" rel="noreferrer" target="_blank">http://www.ensembl.info/</a><br>
</font></span></blockquote></div><br></div>